Scholarlink

Background <p>Currently, it remains unclear whether patients with lymphedema (LE) exhibit lipid metabolism disorders. This study aimed to profile serum lipid factors associated with LE and evaluate their clinical diagnostic value.</p> Materials and methods <p>Differentially expressed proteins (DEPs) were identified by comparing serum lipid profiles between LE patients and normal controls (NC). Bioinformatics analyses were subsequently conducted to identify lipid metabolism-related proteins in LE patients. Enzyme-linked immunosorbent assay (ELISA) and receiver operating characteristic (ROC) curve analysis were employed to validate and evaluate the diagnostic potential of candidate proteins.</p> Results <p>Enrichment analysis of DEPs revealed that the cholesterol metabolism pathway was prominently enriched in the serum of LE patients. Annotated proteins involved in this pathway included beta-2-glycoprotein 1 (β2GPI), apolipoprotein A-I (Apo-AI), apolipoprotein E (Apo-E), apolipoprotein C-III (ApoC-III), apolipoprotein B-100 (ApoB-100), phosphatidylcholine–sterol acyltransferase (LCAT), and phospholipid transfer protein (PLTP). Among these, β2GPI was confirmed to be significantly upregulated in the serum of LE patients by ELISA (<i>p</i> &lt; <i>0.05</i>). ROC analysis demonstrated that serum β2GPI effectively distinguished LE patients from controls, with AUCs of 0.873 (95% CI 0.749–0.998, <i>p</i> &lt; <i>0.05</i>) for primary LE (PLE) and 0.871 (95% CI 0.738–1.000, <i>p</i> &lt; <i>0.05</i>) for secondary LE (SLE). For PLE diagnosis, β2GPI exhibited 80.0% sensitivity and 86.7% specificity. For SLE diagnosis, it showed 86.7% for both sensitivity and specificity.</p> Conclusions <p>Abnormal expression of cholesterol metabolism-related proteins was observed in the serum of LE patients. Among these, β2GPI was validated to be significantly upregulated, demonstrating its potential clinical diagnostic value.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Proteins related to cholesterol metabolism were screened and identified in the serum of lymphedema patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月6日

查看全文
  • Qian Meng,
  • Man Zhang

摘要

Background

Currently, it remains unclear whether patients with lymphedema (LE) exhibit lipid metabolism disorders. This study aimed to profile serum lipid factors associated with LE and evaluate their clinical diagnostic value.

Materials and methods

Differentially expressed proteins (DEPs) were identified by comparing serum lipid profiles between LE patients and normal controls (NC). Bioinformatics analyses were subsequently conducted to identify lipid metabolism-related proteins in LE patients. Enzyme-linked immunosorbent assay (ELISA) and receiver operating characteristic (ROC) curve analysis were employed to validate and evaluate the diagnostic potential of candidate proteins.

Results

Enrichment analysis of DEPs revealed that the cholesterol metabolism pathway was prominently enriched in the serum of LE patients. Annotated proteins involved in this pathway included beta-2-glycoprotein 1 (β2GPI), apolipoprotein A-I (Apo-AI), apolipoprotein E (Apo-E), apolipoprotein C-III (ApoC-III), apolipoprotein B-100 (ApoB-100), phosphatidylcholine–sterol acyltransferase (LCAT), and phospholipid transfer protein (PLTP). Among these, β2GPI was confirmed to be significantly upregulated in the serum of LE patients by ELISA (p < 0.05). ROC analysis demonstrated that serum β2GPI effectively distinguished LE patients from controls, with AUCs of 0.873 (95% CI 0.749–0.998, p < 0.05) for primary LE (PLE) and 0.871 (95% CI 0.738–1.000, p < 0.05) for secondary LE (SLE). For PLE diagnosis, β2GPI exhibited 80.0% sensitivity and 86.7% specificity. For SLE diagnosis, it showed 86.7% for both sensitivity and specificity.

Conclusions

Abnormal expression of cholesterol metabolism-related proteins was observed in the serum of LE patients. Among these, β2GPI was validated to be significantly upregulated, demonstrating its potential clinical diagnostic value.